NCT06490510View on ClinicalTrials.gov

Prognostic Significance of Mutation Type and Chromosome Fragility in Fanconi Anemia

CompletedOBSERVATIONAL
Enrollment

227

Participants

Timeline

Start Date

May 16, 2024

Primary Completion Date

June 18, 2024

Study Completion Date

June 18, 2024

Conditions
Fanconi Anemia
Trial Locations (1)

08041

Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau - IIB Sant Pau, Barcelona

All Listed Sponsors
lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

NCT06490510 - Prognostic Significance of Mutation Type and Chromosome Fragility in Fanconi Anemia | Biotech Hunter | Biotech Hunter